This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It’s even being used to review investigator invoices and automate financial reconciliations—a monthly headache every contract research organization, sponsor, and clinicaltrials operator will be more than happy to resign to machines. Yet, the opportunity extends beyond simply increasing profitability.
Home visits for clinicaltrials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.
Home visits for clinicaltrials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.
Home visits for clinicaltrials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.
Home visits for clinicaltrials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.
To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinicaltrials. The post Complexity in Early Phase ClinicalTrials with Dr. Oren Cohen? The post Complexity in Early Phase ClinicalTrials with Dr. Oren Cohen?
As the rush for a COVID-19 vaccine continues, healthcare services company Kaiser Permanente has joined in on the clinical testing of Pfizer Inc. and BioNTech’s lead vaccine candidate in a Phase III trial being conducted at sites in California and Oregon. Kaiser began Phase III trials of the vaccine at the end of July.
Dr. Amy Chan, senior clinicalresearch fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years. 037) Platforms enable researchers and practitioners to see what and when inhalers have been used and whether they have been used correctly.
Food allergies. Food allergies. Find a ClinicalTrial for Atopic Dermatitis. However, If you are looking for additional relief, you may want to consider enrolling in a clinicaltrial. The post A Comprehensive Guide to Atopic Dermatitis appeared first on Olympian ClinicalResearch.
November 16, 2020 — An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial oversight group on Nov. 37% of trial volunteers are from racial and ethnic minorities.
announced that the first participant has been dosed in a new Phase I trial for an innovative HIV vaccine candidate, VIR-1388. The trial’s primary objective is to assess the safety of VIR-1388 and its capacity to stimulate a specific immune response against HIV in study participants. Vir Biotechnology, Inc.,
Researchers are exploring a potential cancer treatment. Researchers are inviting healthy males to join this paid clinicaltrial. If you are generally healthy and want to advance medical research, consider joining! Participants may help researchers further develop cancer treatments. Why Participate? .
Allergies: due to a rise of inflammation in the body, allergies can trigger migraines. Contact Olympian ClinicalResearch. At Olympian ClinicalResearch, we understand the debilitating effects that migraines can have on a person’s quality of life.
The acquisition of KO-MED is Velocity’s first foray into Oncology research, which accounts for roughly 40-50% of clinicaltrials globally. KO-MED has been the leading multi-site network in Poland since 2020, having enrolled over 9,000 patients into clinicalresearch.
In addition, your child’s doctor will likely recommend an antihistamine , which is a kind of drug that treats allergies to help with itching. Contact Olympian ClinicalResearch . If your child is affected by pediatric psoriasis, contact Olympian ClinicalResearch today to see if your child qualifies for our clinicaltrial.
This is especially true for those with a history of skin sensitivity or allergies, as well as those with pre-existing eczema. Soothe Your Eczema Symptoms with Olympian ClinicalResearch At Olympian ClinicalResearch (OCR), we believe that everyone deserves relief from the frustration and discomfort of eczema.
Importantly, the AU/EU model allows biotechs to keep their data and trial management in Australia, and take advantage of the Australian cash rebate of up to 43.5% on clinicaltrial costs, throughout all study phases, across both regions. “We But it was a true Eureka moment when we realized that combining Australia’s 43.5%
By extracting essential details from medical records, including medical history, test results and allergies, ChatGPT can present doctors with a comprehensive overview of a patient’s health status. Starting this year, PreDX has been launched and Credo is currently offering healthcare providers a free trial for the first 20 patients.
Webinar Takeaways In light of recent draft guidance from the FDA on core patient-reported outcomes (PROs) in cancer trials and on dose optimization in oncology drug development – thoughtful collection and interpretation of patient experience data in oncology clinicalresearch is becoming even more critical.
Webinar Takeaways In light of recent draft guidance from the FDA on core patient-reported outcomes (PROs) in cancer trials and on dose optimization in oncology drug development – thoughtful collection and interpretation of patient experience data in oncology clinicalresearch is becoming even more critical.
Webinar Takeaways In light of recent draft guidance from the FDA on core patient-reported outcomes (PROs) in cancer trials and on dose optimization in oncology drug development – thoughtful collection and interpretation of patient experience data in oncology clinicalresearch is becoming even more critical.
December 2, 2020) – Clinicalresearch presented by Octapharma USA at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition will highlight the investigational use of high-dose Octagam® 10% [Immune Globulin Intravenous (Human)] […].
Webinar Takeaways In light of recent draft guidance from the FDA on core patient-reported outcomes (PROs) in cancer trials and on dose optimization in oncology drug development – thoughtful collection and interpretation of patient experience data in oncology clinicalresearch is becoming even more critical.
and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S.
Carlsbad, California-based Ionis Pharmaceuticals announced it will be sharing promising new trial data for its RNA-targeted prophylactic treatment donidalorsen for hereditary angioedema (HAE) at the 2025 American Academy of Allergy, Asthma & Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress in San Diego, California.
At the beginning of September, Velocity ClinicalResearch topped Business North Carolina ’s 2024 Fast 40 list. For a clinicaltrials organization to achieve this level of scale is notable. Recruitment Clinicaltrial sites live and die by their ability to recruit patients into trials.
And while this means that most of us can get outside and enjoy the nice weather, it means something different to allergy sufferers. If you have seasonal allergies, then you know how painful and annoying your symptoms can be. Certain symptoms might have you wondering- is it allergies or COVID? Is it Allergies or COVID symptoms?
The case report, published in the New England Journal of Medicine that same month, began the rigorous journey of establishing Veklury’s efficacy and safety profile as a COVID-19 treatment in multiple global, randomized, controlled clinicaltrials – even as scientists were still learning about the course of the disease itself.
The NDA was built on data from the Phase III VICTORIA trial. It was co-sponsored by Merck and Bayer, conducted with the scientific oversight of the Canadian VIGOUR Centre and the Duke ClinicalResearch Institute. The NDA was supported by results from two pivotal trials, Phase III AURORA and Phase II AURA-LV.
and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S.
and Shionogi Limited as shareholders, today announced that an independent data safety monitoring board (DSMB) recommended the early unblinding of the HIV Prevention Trials Network (HPTN) 084 study evaluating the safety and efficacy of investigational, long-acting, injectable cabotegravir for HIV prevention in women. Cohen, M.D.,
Vera Therapeutics bags USD 80 Million for trials. Vera Therapeutics has raised USD 80 million to take a drug licensed from Merck KGaA into a phase 2b kidney disease clinicaltrial. The drug, atacicept, has flunked multiple autoimmune clinicaltrials, but Vera contemplates that it is a prospect in IgA nephropathy.
Bayer’s Astepro (azelastine), an over-the-counter medication for cold, flu and allergies, led the pack in the first half of 2023 with 7.4 9. 10 Trends and Statistics for ClinicalTrials in 2023 Several key trends in clinicaltrials have been shaping the landscape of the field this year. billion ad impressions.
A Phase 2 clinicaltrial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. “This trial will help us understand if we can use prototype and variant vaccines alone or together to shift immune responses to cover existing and emerging COVID-19 variants.”
With a presidential inauguration and a federal holiday, it wasn’t an enormously busy week for clinicaltrial news, but there was a fair amount, nonetheless. It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. Read on to see. COVID-19-Related.
Manning of Allergy, Asthma and Immunology Associates, Ltd., Current treatments for HAE fall into two main categories: on-demand (acute) treatments to stop an attack and LTP therapies to prevent attacks. Dr. Michael E. presented findings on sebetralstats use in patients receiving berotralstat, an oral LTP therapy. attacks per month.
In this blog, we explore the legacy of Black trailblazers in science, spotlight modern leaders driving innovation and examine efforts to improve representation in clinicalresearch and biotech leadership while addressing ongoing challenges in equitable healthcare.
By the end of August, the World Health Organization (WHO) counted 33 vaccine candidates in some stage of clinicaltrial evaluation. As of July, the company and its federal partner stated that it is on track to supply between 500 million to 1 billion doses a year at a dose of 100 µg now selected for their Phase III trial.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content